Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Contrast Media & Molecular Imaging|November 4, 2017
CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based ApproachesDiana Spiegelberg, Johan Nilvebrant
STAR Protocols|January 17, 2025
Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometryKatrine Ingelshed, Marit M Melssen, Diana Spiegelberg
International Journal of Oncology|October 23, 2019
The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cellsSara Lundsten, Diana Spiegelberg, Bo Stenerlöw, et al.
European Biophysics Journal : EBJ|July 24, 2021
KD determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurementsDiana Spiegelberg, Jonas Stenberg, Pascale Richalet, et al.
Nuclear Medicine and Biology|December 3, 2013
Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6Jonas Stenberg, Diana Spiegelberg, Hampus Karlsson, et al.
Nuclear Medicine and Biology|December 26, 2015
A real-time in vitro assay as a potential predictor of in vivo tumor imaging propertiesDiana Spiegelberg, Jonas Stenberg, Anna-Karin Haylock, et al.
Cancers|October 27, 2022
Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive ProteinDiana Spiegelberg, Christer Malmberg, Ylva Tiblom Ehrsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2020
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenograftsSara Lundsten, Diana Spiegelberg, Nakul R Raval, et al.
Translational Oncology|September 20, 2022
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell linesAndris Abramenkovs, Mehran Hariri, Diana Spiegelberg, et al.
EJNMMI Research|March 7, 2014
In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope studyAnna-Karin Haylock, Diana Spiegelberg, Johan Nilvebrant, et al.
Pageof 4